Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GOSS Gossamer Bio > Detailed Quotes

GOSS Gossamer Bio

12.140
-0.140-1.14%
Close 09/23 16:00 ET
High
12.170
Open
12.040
Turnover
14.09M
Low
11.650
Pre Close
12.280
Volume
1.18M
Market Cap
1.14B
P/E(TTM)
Loss
52wk High
15.195
Shares
93.95M
P/E(Static)
Loss
52wk Low
5.640
Float Cap
945.58M
Bid/Ask %
-71.43%
Historical High
27.150
Shs Float
77.89M
Volume Ratio
0.70
Historical Low
5.640
Dividend TTM
--
Div Yield TTM
1000
P/B
-69.37
Dividend LFY
--
Div Yield LFY
8237.23%
Turnover Ratio
1.51%
Amplitude
4.24%
Avg Price
11.976
Lot Size
1
Float Cap
945.58M
Bid/Ask %
-71.43%
Historical High
27.150
Shs Float
77.89M
Volume Ratio
0.70
Historical Low
5.640
Dividend TTM
--
P/B
-69.37
Dividend LFY
--
Turnover Ratio
1.51%
Amplitude
4.24%
Avg Price
11.976
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA.
CEO: Mr. Faheem Hasnain
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...